News

5 Sep 2019
EORTC driving the policy agenda for clinical cancer research in Europe

31 Jul 2019
PRESS RELEASE: EORTC and ESTRO announce E2-RADIatE platform’s first site activation for Oligometastatic Disease

11 Jul 2019
EORTC at ISCB 40, Annual Conference of the International Society for Clinical Biostatistics

3 Jun 2019
Defining the best treatment for locally advanced cervical cancer

3 Jun 2019
Assessment of a potential new treatment option for patients with metastatic gastrointestinal stromal tumor (GIST) that may overcome resistance to established compounds

3 Jun 2019
Looking for answers in the search for the best treatment of retroperitoneal sarcoma

1 Jun 2019
Sustained long term survival benefit with adjuvant ipilimumab in patients with high risk stage III melanoma

31 May 2019
Preliminary results confirm that the addition of bone-protecting agents to Radium-233 (Ra-233) treatment can limit fractures in metastatic castration resistant prostate cancer patients

20 May 2019
EORTC abstracts selected at ASCO

13 May 2019
EORTC proudly joins Walgreens Boots Alliance in a Transatlantic Charitable Partnership that aims to meet the needs of people living with cancer

